Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mississippi Business Today.
Press releases published on July 3, 2025
Lumine Group Completes the Purchase of Datafusion Systems
TORONTO, July 03, 2025 (GLOBE NEWSWIRE) -- Lumine Group Inc. (“Lumine Group” or “the Company”) (TSXV: LMN), a global buy-and-hold forever acquirer of communications and media software businesses, today announced that it has completed the purchase of …
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BEDFORD, Mass., July 03, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on July 1, …
Preferred Bank Announces 2025 Second Quarter Earnings Release and Conference Call
LOS ANGELES, July 03, 2025 (GLOBE NEWSWIRE) -- Preferred Bank (NASDAQ: PFBC), one of the larger independent commercial banks in California, today announced plans to release its financial results for the second quarter ended June 30, 2025 before the open of …
TransAlta to Host Second Quarter 2025 Results Conference Call
CALGARY, Alberta, July 03, 2025 (GLOBE NEWSWIRE) -- TransAlta Corporation (“TransAlta”) (TSX:TA)(NYSE:TAC) will release its second quarter 2025 results before markets open on Friday, August 1, 2025. A conference call and webcast to discuss the results will …
Bioma Probiotics Redefines Digestive Health in 2025 With Its Strongest Prebiotic, Probiotic, and Postbiotic Synergy Yet
San Francisco, July 03, 2025 (GLOBE NEWSWIRE) -- Section 1 – Introduction The increasing visibility of the gut microbiome in health-related online searches continues to reshape public interest in non-clinical wellness solutions. In particular, consumer …
EQV Ventures Acquisition Corp. II Announces Closing of Upsized $460 Million Initial Public Offering and Partial Exercise of Over-Allotment Option
PARK CITY, UTAH, July 03, 2025 (GLOBE NEWSWIRE) -- EQV Ventures Acquisition Corp. II (the “Company”), a special purpose acquisition company sponsored by an affiliate of the EQV Group, and formed for the purpose of entering into a business combination with …
PhenQ Updates 2025 Formula With Strongest OTC Appetite Suppressant Profile and Clinically Studied Craving Support Ingredients
Austin, July 03, 2025 (GLOBE NEWSWIRE) -- Section 1 – Introduction As public discourse around weight management increasingly centers on metabolic wellness and lifestyle sustainability, interest in ingredient transparency and multi-pronged dietary support …
JCPal Unveils Award-Winning Range of Shortcut Keyboards for Creative Professionals
Vancouver, Canada , July 03, 2025 (GLOBE NEWSWIRE) -- JCPal Technology, a global leader in the design and manufacturing of premium tech accessories, announced today the launch of Dash, an innovative range of wireless shortcut keyboards built specifically …
Community Impact Coalition Commends Congressional Approval of “One Big Beautiful Bill,” Protecting Nonprofit Tax Status
Washington, DC, July 03, 2025 (GLOBE NEWSWIRE) -- The Community Impact Coalition (CIC), a network of over 100 national and state nonprofits, today celebrates the final passage of the “One Big Beautiful Bill Act,” which protects critical nonprofit tax …
Opus Genetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
RESEARCH TRIANGLE PARK, N.C., July 03, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule therapies for …
USCB Financial Holdings, Inc. To Announce Second Quarter 2025 Results
MIAMI, July 03, 2025 (GLOBE NEWSWIRE) -- USCB FINANCIAL HOLDINGS, INC. (the “Company”) (NASDAQ: USCB) will report financial results for the quarter ended June 30, 2025 after the market closes on Thursday, July 24, 2025. A conference call to discuss …
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …